The Role of Platelets in Diabetic Kidney Disease

被引:16
作者
Rustiasari, Ukhti Jamil [1 ,2 ,3 ]
Roelofs, Joris J. [1 ,2 ]
机构
[1] Univ Amsterdam, Amsterdam UMC, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Amsterdam Cardiovasc Sci, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Islam Indonesia, Fac Med, Dept Anat Pathol, Yogyakarta 55584, Indonesia
关键词
diabetes; diabetic kidney disease; diabetic nephropathy; platelets; platelet activation; biomarker; antiplatelet; SOLUBLE CD40 LIGAND; DRUG DILAZEP DIHYDROCHLORIDE; PLASMA BETA-THROMBOGLOBULIN; GLOMERULAR MESANGIAL CELL; FIBROBLAST-GROWTH-FACTOR; CHRONIC-RENAL-FAILURE; BERAPROST SODIUM; ACTIVATING-FACTOR; P-SELECTIN; ADHESION MOLECULES;
D O I
10.3390/ijms23158270
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Diabetic kidney disease (DKD) is among the most common microvascular complications in patients with diabetes, and it currently accounts for the majority of end-stage kidney disease cases worldwide. The pathogenesis of DKD is complex and multifactorial, including systemic and intra-renal inflammatory and coagulation processes. Activated platelets play a pivotal role in inflammation, coagulation, and fibrosis. Mounting evidence shows that platelets play a role in the pathogenesis and progression of DKD. The potentially beneficial effects of antiplatelet agents in preventing progression of DKD has been studied in animal models and clinical trials. This review summarizes the current knowledge on the role of platelets in DKD, including the potential therapeutic effects of antiplatelet therapies.
引用
收藏
页数:35
相关论文
共 218 条
  • [1] PLATELET-DERIVED GROWTH-FACTOR AND MESANGIAL CELLS
    ABBOUD, HE
    [J]. KIDNEY INTERNATIONAL, 1992, 41 (03) : 581 - 583
  • [2] Abdelwhab S., 2010, Kidney, V19, P229, DOI [10.1007/s00596-010-0156-4, DOI 10.1007/S00596-010-0156-4]
  • [3] Diabetes mellitus and platelet reactivity in patients under prasugrel or ticagrelor treatment: an observational study
    Alexopoulos, Dimitrios
    Vogiatzi, Chrysoula
    Stavrou, Katerina
    Vlassopoulou, Niki
    Perperis, Angelos
    Pentara, Ioanna
    Xanthopoulou, Ioanna
    [J]. CARDIOVASCULAR DIABETOLOGY, 2015, 14
  • [4] Platelet reactivity during ticagrelor maintenance therapy: A patient-level data meta-analysis
    Alexopoulos, Dimitrios
    Xanthopoulou, Ioanna
    Storey, Robert F.
    Bliden, Kevin P.
    Tantry, Udaya S.
    Angiolillo, Dominick J.
    Gurbel, Paul A.
    [J]. AMERICAN HEART JOURNAL, 2014, 168 (04) : 530 - 536
  • [5] Ali Ramadan A, 2015, Curr Trends Immunol, V16, P65
  • [6] Diabetic Kidney Disease Challenges, Progress, and Possibilities
    Alicic, Radica Z.
    Rooney, Michele T.
    Tuttle, Katherine R.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 12 (12): : 2032 - 2045
  • [7] DIFFERENT EFFECTS OF RENAL-FAILURE ON BETA-THROMBOGLOBULIN AND HIGH-AFFINITY PLATELET FACTOR-4 (HA-PF4) - CONCENTRATIONS
    ANDRASSY, K
    DEPPERMANN, D
    RITZ, E
    KODERISCH, J
    SEELIG, H
    [J]. THROMBOSIS RESEARCH, 1980, 18 (3-4) : 469 - 475
  • [8] Platelet-derived CD40L -: The switch-hitting player of cardiovascular disease
    André, P
    Nannizzi-Alaimo, L
    Prasad, SK
    Phillips, DR
    [J]. CIRCULATION, 2002, 106 (08) : 896 - 899
  • [9] Clopidogrel withdrawal is associated with proinflammatory and prothrombotic effects in patients with diabetes and coronary artery disease
    Angiolillo, DJ
    Fernandez-Ortiz, A
    Bernardo, E
    Ramírez, C
    Sabaté, M
    Jimenez-Quevedo, P
    Hernández, R
    Moreno, R
    Escaned, J
    Alfonso, F
    Bañuelos, C
    Costa, MA
    Bass, TA
    Macaya, C
    [J]. DIABETES, 2006, 55 (03) : 780 - 784
  • [10] [Anonymous], 2021, Chronic Kidney Disease in the United States